Core Points - The National Medical Products Administration has approved a new industry standard for medical devices using brain-computer interface (BCI) technology, which will take effect on January 1, 2026, addressing long-standing issues of terminology confusion in the field [1] - A series of supportive policies have been introduced in 2023 to facilitate the application of BCI technology in healthcare, including pricing guidelines for invasive and non-invasive BCI services [2][3] - The market for BCI applications in healthcare is projected to reach $40 billion by 2030, with significant potential in serious medical applications and consumer healthcare [4] Policy Developments - In March 2023, the National Healthcare Security Administration issued guidelines for pricing BCI-related medical services, establishing clear pricing categories for invasive and non-invasive procedures [2] - Zhejiang Province has implemented specific pricing for BCI services, with costs set at 6,580 yuan for invasive implantation, 3,150 yuan for removal, and 960 yuan for non-invasive adaptation [2] - In August 2023, Zhejiang Province announced that non-invasive BCI adaptation fees would be included in basic medical insurance, reducing the out-of-pocket cost for patients to 10% [2] Industry Trends - The clarity in pricing is expected to promote standardized applications of BCI technology in healthcare, reducing competition chaos and attracting more investment [3] - Companies are increasingly investing in the "BCI + healthcare" sector, with notable advancements in practical applications, such as the launch of the first domestic BCI-assisted rehabilitation system for upper limb function [5] - Innovative companies like Zhejiang Qiangnao Technology are emerging as key players in the industry, focusing on non-invasive BCI technologies and developing smart prosthetic products [5] Future Outlook - Experts predict that ongoing research will lead to significant improvements in BCI technology, expanding its applications beyond current disease treatments to a broader range of medical fields [6] - The convergence of favorable policies, standards, capital, and technology is seen as a catalyst for the BCI medical application sector, with early movers likely to gain a competitive edge [6]

同济医院携46项成果亮相，这些成果多为全国甚至全球首创。其中，由该院领衔重磅发布的10项成果， 聚焦脑机接口、基因诊疗、手术机器人、智慧医疗平台等前沿领域，通过中央电视台的直播，向全球呈 现了湖北医疗科技的硬核实力。 长江商报消息 ●长江商报记者 刘倩雯 华中首个脑机接口门诊落地武汉之后，湖北脑机接口产业创新发展联盟正式成立。 8月9日，湖北省医疗科技创新成果发布会在华中科技大学附属同济医院光谷院区（以下简称"同济医 院"）举行，同济医院携46项成果亮相。 2025年6月，华中科技大学同济医学院附属同济医院正式启用华中地区首个脑机接口（BCI）门诊，这 里不仅成功实施华中首例植入式脑机接口手术，更建立了全国首个脑机接口医保数据研究中心，让意识 控制机械不再是科幻电影场景，标志着湖北在神经科学与人工智能医疗应用领域迈出关键一步。 8月1日，58岁的高女士在湖北武汉同济医院通过华中首例植入式脑机接口技术，仅凭意念驱动手套完成 自主喝水动作。一个月前，她因车祸高位截瘫接受手术。医生将两个1元硬币大小的电极精准植入到高 女士左侧脑部硬膜外手部运动和感觉区，不触碰脑组织即能捕捉大脑与手部运动的神经信号。术后通 过"脑控 ...